Intelligence · Clinical Pipeline
Vanda Pharmaceuticals Netherlands Pipeline
All ClinicalTrials.gov programs at Vanda Pharmaceuticals Netherlands — phase, modality, and trial IDs.
- Programs
- 21
Quick answer
Vanda Pharmaceuticals Netherlands has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
20 mg VEC-162
Vanda Pharmaceuticals Netherlands B.V.
Insomnia
1 trial -
750 mg Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Double-blind 200 mg imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Bipolar I Disorder
2 trials -
Milsaperidone
Vanda Pharmaceuticals Netherlands B.V.
Major Depressive Disorder (MDD)
1 trial -
Placebo will be provided in size and appearance identical to those containing milsaperidone and will be administered orally., Milsaperidone, Milsaperidone, Milsaperidone
Vanda Pharmaceuticals Netherlands B.V.
Major Depressive Disorder
1 trial -
Ponesimod
Vanda Pharmaceuticals Netherlands B.V.
Moderate-to-severe Chronic Plaque Psoriasis
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Jet Lag Type Insomnia
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Sleep Wake Disorders
2 trials -
Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension
Vanda Pharmaceuticals Netherlands B.V.
Autism Spectrum Disorder
1 trial -
Tasimelteon Oral Suspension
Vanda Pharmaceuticals Netherlands B.V.
Insomnia Disorder
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Nausea and Vomiting
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Idiopathic Gastroparesis
2 trials -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Motion Sickness
4 trials -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Atopic Dermatitis
3 trials -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Coronavirus Infection
1 trial -
VEC-162 20 mg
Vanda Pharmaceuticals Netherlands B.V.
Primary Insomnia
1 trial -
VQW-765
Vanda Pharmaceuticals Netherlands B.V.
Social Anxiety Disorder (SAD)
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Smith-Magenis Syndrome
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Major Depressive Disorder
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Non 24 Hour Sleep Wake Disorder
4 trials
Frequently asked questions
How many pipeline programs does Vanda Pharmaceuticals Netherlands have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs